{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:56:42Z","timestamp":1760029002446,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijcard.2016.03.079","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T06:58:14Z","timestamp":1458802694000},"page":"360-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cardiovascular disorders associated with naloxone monotherapy and in fixed-dose combination with opioids: Data from international safety surveillance"],"prefix":"10.1016","volume":"212","author":[{"given":"Amneet","family":"Sandhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip S.","family":"Mehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.P.","family":"Haigney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mori J.","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.03.079_bb0005","first-page":"e41","article-title":"Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000\u20132010","volume":"6","author":"Kenan","year":"2012","journal-title":"Open Med."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/pme.12613","article-title":"Use of opioids and other analgesics by older adults in the United States, 1999\u20132010","volume":"16","author":"Steinman","year":"2015","journal-title":"Pain Med."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0015","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0020","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1503\/cmaj.051528","article-title":"Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects","volume":"174","author":"Furlan","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0025","first-page":"1045","article-title":"Opioid-related bowel dysfunction: prevalence and identification of predictive factors in a large sample of Italian patients on chronic treatment","volume":"14","author":"Rosti","year":"2010","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0030","unstructured":"Food and Drug Administration - Center for Drug Evaluation and Research. Application Number 21775. (Accessed December 16th, 2015, at http:\/\/www.fda.gov\/downloads\/advisorycommittees\/committeesmeetingmaterials\/drugs\/anestheticandanalgesicdrugproductsadvisorycommittee\/ucm400205.pdf.)"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0035","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12325-014-0131-y","article-title":"Description of cardiovascular event rates in patients initiating chronic opioid therapy for noncancer pain in observational cohort studies in the US, UK, and Germany","volume":"31","author":"LoCasale","year":"2014","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0040","unstructured":"MedDRA Use at the FDA. (Accessed accessed 2014, Jun 6, 2010, at http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/Training\/GCG_-_Endorsed_Training_Events\/ASEAN_MedDRA_March_2010\/Day_3\/Regulatory_Perspective_SBrajovic.pdf, archived at http:\/\/www.webcitation.org\/6VLUGngEp.)"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0045","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.ijmedinf.2009.01.001","article-title":"Influence of the MedDRA hierarchy on pharmacovigilance data mining results","volume":"78","author":"Pearson","year":"2009","journal-title":"Int. J. Med. Inform."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pds.2630030105","article-title":"The medical dictionary for drug regulatory affairs (MEDDRA) project","volume":"3","author":"Wood","year":"1994","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0055","unstructured":"What are the structural elements of the terminology in MedDRA? http:\/\/www.meddra.org\/faq. (Accessed 11 Nov, 2015, at http:\/\/www.meddra.org\/faq.)"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2165\/00002018-200730070-00009","article-title":"Standardised MedDRA queries: their role in signal detection","volume":"30","author":"Mozzicato","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00002018-200326030-00003","article-title":"Quantitative methods in pharmacovigilance: focus on signal detection","volume":"26","author":"Hauben","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0080","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2165\/00002018-200730080-00008","article-title":"Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer","volume":"30","author":"Matsushita","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/11534410-000000000-00000","article-title":"Validation of statistical signal detection procedures in eudravigilance post-authorization data: a retrospective evaluation of the potential for earlier signalling","volume":"33","author":"Alvarez","year":"2010","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0090","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-158-10-201305210-00008","article-title":"Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data","volume":"158","author":"Kao","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0095","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/add.13013","article-title":"Arrhythmia associated with buprenorphine and methadone reported to the food and drug administration","volume":"110","author":"Kao","year":"2015","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.ijcard.2016.03.079_bb0100","first-page":"409","article-title":"VigiBase, the WHO global ICSR database system: basic facts","volume":"42","author":"Lindquist","year":"2008","journal-title":"Ther. Innov. Regul. Sci."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0105","unstructured":"VigiBase. http:\/\/www.who-umc.org. (Accessed 11 Nov, 2015, at who-umc.org.)"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0110","unstructured":"Food and Drug Administration: FAERS Database. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/. (Accessed 12 Nov, 2015, at http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/.)"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0115","unstructured":"FAERS Statistics. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm070093.htm. (Accessed 12 Nov, 2015, at http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm070093.htm.)"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0120","first-page":"84","article-title":"Heart failure due to \u2018stress cardiomyopathy\u2019: a severe manifestation of the opioid withdrawal syndrome","volume":"2","author":"Spadotto","year":"2013","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0125","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/S0735-1097(00)01011-1","article-title":"Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle","volume":"36","author":"Bell","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0130","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0735-1097(99)00095-9","article-title":"Effects of naloxone on myocardial ischemic preconditioning in humans","volume":"33","author":"Tomai","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0135","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(81)92865-8","article-title":"Pressor effect of naloxone in septic shock","volume":"1","author":"Peters","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0140","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1139\/y81-189","article-title":"The reversal of hemorrhagic hypotension by naloxone in conscious rabbits","volume":"59","author":"Schadt","year":"1981","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0145","unstructured":"Food and Drug Administration: Center for Drug Evaluation and Research. Briefing Document \u2014 Anesthetic and analgesic drug products advisory committee meeting. (Accessed December 15th, 2015, at http:\/\/www.fda.gov\/downloads\/advisorycommittees\/committeesmeetingmaterials\/drugs\/anestheticandanalgesicdrugproductsadvisorycommittee\/ucm400205.pdf.)"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0150","unstructured":"FDA News Release: Approval of Relistor for Opioid-Induced Constipation. (Accessed December 18th, 2015, at http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/2008\/ucm116885.htm.)"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0155","unstructured":"FDA News Release: Approval of Montavik for Opioid-Induced Constipation. (Accessed December 18th, 2015, at http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm414620.htm.)"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0160","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jpain.2008.06.014","article-title":"Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain","volume":"9","author":"Vondrackova","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpain.2008.06.012","article-title":"A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation","volume":"13","author":"Meissner","year":"2009","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0170","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMp1011512","article-title":"A flood of opioids, a rising tide of deaths","volume":"363","author":"Okie","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.03.079_bb0175","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.2015.11859","article-title":"Nonmedical prescription opioid use and use disorders among adults aged 18 through 64years in the United States, 2003-2013","volume":"314","author":"Han","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.03.079_bb0180","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316305010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316305010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:40:10Z","timestamp":1759092010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316305010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":36,"alternative-id":["S0167527316305010"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.079","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disorders associated with naloxone monotherapy and in fixed-dose combination with opioids: Data from international safety surveillance","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}